Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Connect to Use Early Results from China Phase III Trial of Atopic Dermatitis Therapy

publication date: Jul 13, 2022

Connect Biopharma will conduct a primary analysis of its lead drug as a therapy for atopic dermatitis, based on the first 255 patients already enrolled in the China Phase III trial. China’s CDE told the company the 255 patients would be enough for a preliminary efficacy review. The company now plans to report top-line results by the end of 2022. Connect’s CBP-201 targets interleukin-4 receptor alpha (IL-4Rα). Connect must still complete the second Phase of the trial, but the early read-out on Phase I could speed up China approval to 2025. More details....

Stock Symbol: (NSDQ: CNTB)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here